glutamic acid
CAS No. 56-86-0
glutamic acid ( Glutamic Acid; Glutamicol; AI3-18472 )
Catalog No. M18825 CAS No. 56-86-0
(S)-Glutamic acid acts as an excitatory transmitter, shows a direct activating effect on the release of DA from dopaminergic terminals.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 49 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameglutamic acid
-
NoteResearch use only, not for human use.
-
Brief Description(S)-Glutamic acid acts as an excitatory transmitter, shows a direct activating effect on the release of DA from dopaminergic terminals.
-
DescriptionGlutamic Acid is a non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.
-
SynonymsGlutamic Acid; Glutamicol; AI3-18472
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number56-86-0
-
Formula Weight147.13
-
Molecular FormulaC5H9NO4
-
Purity98%
-
Solubility——
-
SMILESC(CC(=O)O)C(C(=O)O)N
-
Chemical NameL-glutamic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Giorguieff MF, et al. Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci Lett. 1977 Oct;6(1):73-7.
molnova catalog
related products
-
Fulvestrant
Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast Y in post-menopausal women with disease progression following anti-estrogen therapy.
-
Ethisterone
Ethisterone is a progestogen hormone being considered to treat prostate Y.
-
CMP8
CMP8 is a selective ligand for estrogen receptor. CMP8 binds to the mutant estrogen receptor ligand binding domain (ERLBD).